A Comparative study between intra-articular corticosteroid injection and ultrasound-guided hydrodilatation in patients with shoulder adhesive capsulitis
Comparison of hydrodilatation with ultrasound guided intra-articular corticosteroid injection in reducing pain and shoulder range of motion improvement in patients with adhesive capsulitis
Design
The research is a randomized double blind clinical trial
on 48 patients
Settings and conduct
Samples are selected from patients with shoulder adhesive capsulitis referred to Imam Reza Clinic divided into two groups The blocked randomized
method is used. After obtaining informed consent, In
control group methylprednisolone is injected intra-articular and in intervention group 0.9% normal saline is injected intra-articular under ultrasonography guidance and Finally effects on pain reduction
and shoulder range of motion improvement are measured.
Participants/Inclusion and exclusion criteria
Presence of pain and shoulder range of motion limitation more than 30 degree in more than two motion plane
Presence of pain and shoulder range of motion limitation more than one month
Shoulder pain after cerebrovascular attack in paretic side
Patients with severe glenohumeral joint osteoarthritis
Patients with complete rotator cuff ligaments tear
Immune deficiency
Fracture in humerus bone or scapula
Pregnant women
Patients with cancer
History of allergy and reaction due in use drugs
Shoulder joint rheumatoid arthritis
Severe depression
Uncontrolled diabetes
Intervention groups
Group A undergoes intra-articular normal saline 0.9%
injection in the affected shoulder Group B undergoes intra-articular methylprednisolone injection using ultrasound guide in the affected shoulder
Main outcome variables
Pain, Shoulder range of motion
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20210910052428N1
Registration date:2021-10-12, 1400/07/20
Registration timing:prospective
Last update:2021-10-12, 1400/07/20
Update count:0
Registration date
2021-10-12, 1400/07/20
Registrant information
Name
Vahide Nadgaran
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 71 3722 2038
Email address
v.nadgaran@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-11-20, 1400/08/29
Expected recruitment end date
2022-03-19, 1400/12/28
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
A Comparative study between intra-articular corticosteroid injection and ultrasound-guided hydrodilatation in patients with shoulder adhesive capsulitis
Public title
"Hydrodilatation in adhesive capsulitis", " Intra-articular corticosteroid in adhesive capsulitis"
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Presence of pain and shoulder range of motion limitation more than 30 degree in more than two motion plane
Presence of pain and shoulder range of motion limitation more than one month
Exclusion criteria:
Shoulder pain after cerebrovascular attack in paretic side
Patients with severe glenohumeral joint osteoarthritis
Patients with complete rotator cuff ligaments tear
Immune deficiency
Fracture in humerus bone or scapula
Pregnant women
Patients with cancer
History of allergy and reaction due in use drugs
Shoulder joint rheumatoid arthritis
Severe depression
Uncontrolled diabetes
Age
No age limit
Gender
Both
Phase
3
Groups that have been masked
Care provider
Outcome assessor
Data analyser
Sample size
Target sample size:
48
Randomization (investigator's opinion)
Randomized
Randomization description
To match patients in the intervention and control groups,
patients are randomly assigned to one of two treatment
groups. The random allocation method in this study will
be the permutation blocks randomization method with 4
samples in each block and a random list of data will be
obtained by using Random Allocation software. We will
have two lists of 24 patients, including the two
intervention and control groups, at random. For
concealment, method of random sequencing is given to
another person who is unaware of the research process,
and the questionnaires are completed by a person
unaware of the division of groups
Blinding (investigator's opinion)
Double blinded
Blinding description
Participants in study Participant: in this study, we does not have the ability to blind the participant because the participant is aware of
receiving each intervention. Clinical care giver: we teach
the caregiver how to complete the questionnaire. This
person is not aware of receiving patient’s intervention.
Researcher: this study does not have the ability to blind
the researcher due to performing both interventions by
himself and being aware of receiving the kind of
intervention in each group. The outcome assessor of the
complete questionnaires is given to a person who is not
aware of the intervention performed and he/she is asked
to determine the level of performance in each person
according to the questionnaires. Data analyzer:
questionnaire are finally given to a person to review the
information. This person does not know any of the steps
of the work and the way of classification in which the
intervention performed.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Shiraz University of Medical Sciences
Street address
No 5/1alley, South eghbale lahoori Ave, Ostad shahriar Ave, Moddaress Blvd
City
Shiraz
Province
Fars
Postal code
7157748857
Approval date
2021-08-30, 1400/06/08
Ethics committee reference number
287.IR .SUMS.MED.REC.1400
Health conditions studied
1
Description of health condition studied
Shoulder adhesive capsulitis
ICD-10 code
M75.00
ICD-10 code description
Adhesive capsulitis of unspecified shoulder
Primary outcomes
1
Description
" Score of pain in visual analoge scale questionnaire" , " Shoulder disability score in shoulder pain and disability index questionnaire"
Timepoint
" Measurement of shoulder range of motion and pain score at the beginning, 2, 4 and 8 weeks after shoulder injection"
Method of measurement
Visual analog scale and shoulder pain and disability index
Secondary outcomes
1
Description
Shoulder Pain
Timepoint
Before intervention; two weeks, four weeks and eight weeks later
Method of measurement
Visual Analogue Scale; Shoulder Pain And Disability Index
2
Description
Shoulder range of motion
Timepoint
Before intervention; two weeks, four weeks and eight weeks later
Method of measurement
With usage of goniometer
Intervention groups
1
Description
Intervention group: injection of normal saline 0.9% with 25cc/sec rate in prevention of capsular rupture due to large amount injection, with injection of 3cc lidocaine under sterile circumstance and with usage of 20 cc syringe in a condition that syringe be parallel to ultrasound probe in semi oblique plane from posterior aspect of shoulder will be done.
Category
Treatment - Drugs
2
Description
Control group: injection of 1 cc methylprednisolone 40 mg/ml plus 1cc lidocaine 2% and 3cc normal saline in a situation that patient is in a prone position and under sterile circumstance and with usage of 20 cc syringe in a condition that syringe be parallel to ultrasound probe in semi oblique plane from posterior aspect of shoulder will be done.
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Imam Reza rehabilitation clinic
Full name of responsible person
Mani Ramzi
Street address
Namazi square
City
shiraz
Province
Fars
Postal code
714737-71348
Phone
+98 71 3212 7002
Email
motahari@sums.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Younes Ghasemi
Street address
خیابان خلیلی، روبروی اموزشگاه معارف
City
shiraz
Province
Fars
Postal code
7134814336
Phone
+98 71 3628 1506
Email
Info@sums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
What processes are involved for a request to access data/document
After sending the desired message, all authors of the
study will be consulted all information will be sent within
a maximum of three weeks if permitted.